
Assistant Professor, Radiology and Biomedical Imaging @YalePET. Research: diabetes, obesity, cortisol. Fordham/Stevens/CCNY Alum (opinions my own)
New Haven, CT
Joined June 2012
- Tweets1.8K
- Following2.3K
- Followers1K
- Likes23.9K
Jason Bini, PhD retweeted
The Yale Stress Center is recruiting 1-2 post-doctoral individuals.
Have questions or want to apply? Contact [email protected] with:
1) Cover letter detailing previous research experience, interests, and career goals
2) CV
3) 3 academic references (name & contact info!
Jason Bini, PhD retweeted
Obesity and neurodegeneration nature.com/articles/s42255-0…
Jason Bini, PhD retweeted
NIH is not issuing awards. You may think that it's because they it is coming up with new directions of research...The apposite is true.
Here is a graph showing how many fewer new funding opportunities that NIH has posted over time.
-91%, a trend that started on Jan 2025.
Jason Bini, PhD retweeted
Stress shapes how we learn, remember, and respond to the world.
A new Yale-led study shows how the stress hormone cortisol alters communication networks in the brain and can strengthen emotional memories. Researcher Elizabeth Goldfarb says the team is also exploring when stress might support learning and adaptation, not just hinder it.
Read more in Yale News: bit.ly/3Ys4UJM
Jason Bini, PhD retweeted
Highlighting the first person to discover evidence of radioactivity, Henri Becquerel, who was born on 15 December 1852.
In 1896 Becquerel discovered radioactivity. This inspired Marie and Pierre Curie to further investigate the phenomenon. They examined many substances and minerals for signs of radioactivity. They found that the mineral pitchblende was more radioactive than uranium and concluded that it must contain other radioactive substances. From it they managed to extract two previously unknown elements, polonium and radium, both more radioactive than uranium.
Becquerel shared the 1903 physics prize with Pierre Curie and Marie Curie, née Skłodowska for their discovery of radioactivity.
Discover more: bit.ly/3n8Lvtf
Jason Bini, PhD retweeted
Up front & free to read in our Dec issue #editorspicks: Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes link.springer.com/article/10…
Jason Bini, PhD retweeted
How is #insulin production affected in residual beta cells in type 1 #diabetes? Préfontaine et al show unexpectedly that stressed senescent beta cells continue to produce mature insulin in the context of type 1 diabetes #DiabetesResearch #T1D #Islets link.springer.com/article/10… 🔓
Jason Bini, PhD retweeted
Towards a better understanding of GLP-1 medicine efficacy beyond PK-incorporation of receptor occupancy and residency time assessed in vivo thelancet.com/journals/ebiom…
Jason Bini, PhD retweeted
Delighted to share the latest paper from our team in Cell Metabolism (cell.com/cell-metabolism/ful…), which has been selected as the cover article for the upcoming December 2025 issue.
In this study, we demonstrate that GLP-1R agonism (using the drug exenatide) confers body-wide multi-omic age-counteraction that rivals rapamycin, the mTOR inhibitor and benchmark anti-aging drug, in aging/aged male mice. Interestingly, we found that this is largely mediated through the hypothalamus in the brain.
Our journey began eight years ago: Upon extensive literature review and in part inspired by the 2017 EXENATIDE-PD trial paper in Lancet, we first hypothesized that GLP-1RAs might have age-counteracting properties. We provided the first experimental evidence connecting aging and GLP-1 agonism in 2020 [nature.com/articles/s41467-0…], showing that exenatide treatment can potently counteract mouse brain vascular aging. We then demonstrated that such an effect extends to most gliovascular cell types in a companion paper in 2021 [nature.com/articles/s42003-0…].
Now, building on our prior works, we are delighted to offer the most direct experimental support to date for the growing discussion that this drug class holds significant anti-aging potential inferred from the expanding list of clinical pleiotropic effects—a topic that was recently raised again by Dr. Lotte Bjerre Knudsen at ARDD 2025 and featured in Nature Biotechnology [nature.com/articles/s41587-0…].
Currently, our clinical team and collaborators are focused on leveraging the anti-aging and anti-neuroinflammatory mechanisms to test GLP-1RAs as treatments for cerebrovascular disorders (ClinicalTrials.gov: NCT05920889 [will be published very soon], NCT06788626 [getting close to the finish line], and NCT05356104 [will take another two years]).
A huge thank you to our entire team and collaborators, editor and reviewers, and to Dr. Jennifer Ma for the cover art that perfectly captures the spirit of our work [stay tuned!], paying tribute to the scientists who made two remarkable discoveries: namely, the isolation of the first GLP-1RA exenatide from Gila monster venom, and rapamycin from Easter Island soil bacteria. Who would have thought that these two natural substances would converge on age-counteraction, at least in the aging mouse!
Jason Bini, PhD retweeted
Excited to share our paper from Bini Lab:
“Morphological and Functional Alterations in Type 2 Diabetes Pancreata assessed with MRI-based metrics and [18F]FP-(+)-DTBZ PET.”
Thank you to Jason Bini and my amazing co-authors for making this work possible!
First official Bini lab preprint is live!
medrxiv.org/content/10.1101/…
Many thanks to @Faraz_Nejati @FrnkEbrahimian Rui Ren and Yuan Huang for their hard work on this study!
@YaleBioImaging
Jason Bini, PhD retweeted
The Lipid Brain Atlas is out now! If you think lipids are boring and membranes are all
the same, prepare to be surprised. Led by Luca Fusar Bassini with Gioele La Manno's lab, we mapped membrane lipids in the mouse brain at high resolution.
biorxiv.org/cgi/content/shor…
Jason Bini, PhD retweeted
The November Issue of @TheLancetEndo is now online, featuring glucocorticoid-induced osteoporosis, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, type 1 diabetes, medical education, older adults, & much more tinyurl.com/mwfu4c6m
Jason Bini, PhD retweeted
β-cell mass does not differ between individuals with and without PBH #Hypoglycemia after RYGB argue against expansion of β-cell mass to explain PBH. diabetesjournals.org/diabete… ada.silverchair-cdn.com/ada/…
Jason Bini, PhD retweeted
We are excited to share the results of the HIRN Data Scholars Leveraging Multi-Modal Human Islet Research Network Knowledge (LINK) competition. Please join us in congratulating Dr. Matthew Ishahak and Dr. Liu Wang on their selection as awardees.
Jason Bini, PhD retweeted
New content online: Health of adipose tissue: oestrogen matters bit.ly/42a2W3c
Jason Bini, PhD retweeted
Type 1 diabetes is associated with a higher risk for all-cause dementia and dementia subtypes. @ADA_Pubs
Read Here➡️ diabetesjournals.org/care/lo…

ALT Infographic titled 'Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study.' The image includes sections on objective, methods, results, and conclusion. It investigates all-cause dementia risks in individuals with type 1 diabetes compared to matched controls, highlighting higher risks and various related factors. Detailed statistical data and icons representing medical themes are present.
Jason Bini, PhD retweeted
Science behind the Study: Replacement of Beta Cells for Type 1 Diabetes nej.md/469fCbF
#Endocrinology #Genetics
Jason Bini, PhD retweeted
Great to finally see this in print! Kathleen Keller and I provide our insight on the Modern Food Environment in the newest edition of Hedonic Eating!
Jason Bini, PhD retweeted
Astrocyte networks are much larger than previously thought, which “flips the way we think about astrocytes and what their networks may mean,” says @LiddelowSA
By @callimcflurry
thetransmitter.org/astrocyte…
Jason Bini, PhD retweeted
The age of immunotherapy for type 1 diabetes is upon us! Thrilled by the opportunity to contribute to this review led by Remi Creusot @Columbia!
#immunologymatters #endt1d
sciencedirect.com/science/ar…

































